highly significantp < 0.01
However, all groups receiving vaccine plus adjuvant had highly significant reductions of at least 78% in the liver sporozoite copy number compared to unimmunized mice (p < 0.01).
However, all groups receiving vaccine plus adjuvant had highly significant reductions of at least 78% in the liver sporozoite copy number compared to unimmunized mice (p < 0.01).
However, alum and AddaVax differed significantly only at 13 and 16 weeks after primary immunization, although those differences approached significance (0.1 > p > 0.05) at weeks 19–25.